BARALDI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 4.827
EU - Europa 3.378
AS - Asia 1.993
SA - Sud America 383
Continente sconosciuto - Info sul continente non disponibili 97
AF - Africa 65
OC - Oceania 6
Totale 10.749
Nazione #
US - Stati Uniti d'America 4.719
FI - Finlandia 1.981
SG - Singapore 633
CN - Cina 552
BR - Brasile 307
DE - Germania 291
VN - Vietnam 269
IT - Italia 266
PL - Polonia 205
HK - Hong Kong 154
GB - Regno Unito 130
TR - Turchia 129
SE - Svezia 117
UA - Ucraina 105
FR - Francia 82
RU - Federazione Russa 72
CA - Canada 62
IN - India 49
BD - Bangladesh 39
JP - Giappone 37
ID - Indonesia 33
ZA - Sudafrica 31
MX - Messico 29
BE - Belgio 26
AR - Argentina 23
NL - Olanda 23
IQ - Iraq 19
ES - Italia 18
AT - Austria 15
CL - Cile 13
EG - Egitto 12
CO - Colombia 11
UZ - Uzbekistan 11
EC - Ecuador 10
IL - Israele 7
PK - Pakistan 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
CZ - Repubblica Ceca 6
TW - Taiwan 6
UY - Uruguay 6
VE - Venezuela 6
AU - Australia 5
LT - Lituania 5
PY - Paraguay 5
SA - Arabia Saudita 5
CR - Costa Rica 4
IE - Irlanda 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
MD - Moldavia 4
NP - Nepal 4
BG - Bulgaria 3
BY - Bielorussia 3
MA - Marocco 3
MY - Malesia 3
PH - Filippine 3
RO - Romania 3
TH - Thailandia 3
AL - Albania 2
AZ - Azerbaigian 2
DZ - Algeria 2
EU - Europa 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
IR - Iran 2
KH - Cambogia 2
MN - Mongolia 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GL - Groenlandia 1
JM - Giamaica 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MC - Monaco 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
NA - Namibia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
Totale 10.650
Città #
Helsinki 1.931
Dallas 773
Ashburn 515
Singapore 433
Fairfield 360
Woodbridge 354
San Jose 249
Ann Arbor 207
Warsaw 201
Beijing 192
Chandler 178
Houston 173
Santa Clara 156
Hong Kong 147
Seattle 144
Wilmington 138
Jacksonville 123
Cambridge 120
Ferrara 108
Council Bluffs 94
Los Angeles 86
Ho Chi Minh City 77
Munich 74
New York 66
Izmir 58
Hanoi 56
Shanghai 43
Milan 40
Nanjing 38
Tokyo 37
Princeton 34
Dong Ket 31
Boardman 29
London 29
São Paulo 29
Brussels 26
Lauterbourg 26
Turku 25
San Diego 23
Orem 21
Buffalo 20
Toronto 20
Bremen 19
Frankfurt am Main 19
Jakarta 19
Addison 18
Brooklyn 16
Chicago 16
Montreal 16
Amsterdam 15
Asnières-sur-Seine 14
Nanchang 14
Shenyang 14
Phoenix 13
Stockholm 13
Mexico City 12
Baghdad 11
Denver 11
Haiphong 11
Jiaxing 11
Atlanta 10
Changsha 10
Chennai 10
Des Moines 10
Hebei 10
Johannesburg 10
Poplar 10
Tashkent 10
Cairo 9
Curitiba 9
Da Nang 9
Moscow 9
Querétaro 9
Rio de Janeiro 9
Ankara 8
Brasília 8
Falls Church 8
Irvine 8
San Francisco 8
Tianjin 8
Washington 8
Belo Horizonte 7
Hefei 7
Mcallen 7
Redwood City 7
Biên Hòa 6
Boston 6
Cape Town 6
Cergy 6
Guangzhou 6
Hải Dương 6
Jinan 6
Manchester 6
Montevideo 6
Montréal 6
Mumbai 6
Norwalk 6
Philadelphia 6
Santiago 6
Auburn Hills 5
Totale 8.053
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 3.111
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 343
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 330
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 315
Design and Synthesis of New A2B Adenosine Receptor Antagonists 312
Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents 301
2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition 299
A3 adenosine receptor antagonists: History and future perspectives 295
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 283
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3’,4’,5’-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 272
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 268
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 258
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 250
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 249
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 244
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 235
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 231
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 217
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 211
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 206
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors 199
Synthesis and biological evaluation of alpha-bromoacryloylamido indolyl pyridinyl propenones as potent apoptotic inducers in human leukaemia cells 177
A 2a adenosine receptor: Structures, modeling, and medicinal chemistry 176
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 168
3-Aryl/Heteroaryl-5-amino-1-(3′,4′,5′-trimethoxybenzoyl)-1,2,4-triazoles as antimicrotubule agents. Design, synthesis, antiproliferative activity and inhibition of tubulin polymerization 167
Adenosine Receptors in Colon Carcinoma Tissues and Colon Tumoral Cell Lines: Focus on the A3 Adenosine Subtype 165
Novel 1,3-Dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as Potent and Selective A2B Adenosine Receptor Antagonists 142
Discovery of 7-oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as potent and selective CB(2) cannabinoid receptor inverse agonists. 137
Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists 137
Design, Synthesis, and Pharmacological Properties of New Heteroarylpyridine/Heteroarylpyrimidine Derivatives as CB2 Cannabinoid Receptor Partial Agonists 128
Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II Inhibitors 128
null 121
null 118
null 103
Synthesis and Biological Evaluation of Novel 2-Amino-3-Aroyl-4-Neopentyl-5-Substituted Thiophene Derivatives as Allosteric Enhancers of the A1 Adenosine Receptor 100
null 96
null 90
null 84
null 83
Totale 10.749
Categoria #
all - tutte 35.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.077
Totale 37.562


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022415 0 25 34 25 36 34 23 24 27 40 36 111
2022/2023438 41 59 8 67 58 55 37 33 47 2 21 10
2023/2024273 19 21 13 9 32 61 8 34 2 6 4 64
2024/20251.063 30 50 92 47 102 96 73 63 144 74 149 143
2025/20265.536 313 308 784 361 442 238 373 159 2.118 282 125 33
2026/2027223 92 131 0 0 0 0 0 0 0 0 0 0
Totale 10.749